Skip to Content

Join the 'Non-Small Cell Lung Cancer' group to help and get support from people like you.

Non-Small Cell Lung Cancer News

Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC

Local Smoke-Free Laws Tied to Fewer Lung Cancer Cases

Posted 6 days ago by

TUESDAY, Dec. 5, 2017 – Communities with strong smoke-free workplace laws have lower lung cancer rates than those with no smoke-free laws, researchers report. The new study was conducted in Kentucky, which has one of the highest lung cancer rates in the United States. University of Kentucky researchers examined 20 years of data on new lung cancer cases among state residents aged 50 and older. The investigators then looked to see whether those with lung cancer lived in communities with strong, moderate or weak smoke-free laws. The lung cancer rate was 8 percent lower in communities with strong smoke-free workplace laws than in communities without smoke-free laws, the findings showed. There were no differences in lung cancer rates between communities with moderate or weak smoking laws and those with no such laws. "Kentucky has one of the highest adult cigarette smoking rates and the ... Read more

Related support groups: Smoking, Smoking Cessation, Lung Cancer, Non-Small Cell Lung Cancer

Lung Cancer Drug Targets 'Hidden' HIV in French Patient

Posted 11 days ago by

FRIDAY, Dec. 1, 2017 – In a case that investigators say is a first, a lung cancer drug unmasked and then attacked the kind of HIV-infected cells that standard antiretroviral therapy has been unable to touch. The finding was reported on Dec. 1, which is also World AIDS Day, in the Annals of Oncology. While one AIDS expert said the findings were promising, she noted the drug did not "cure" the patient of HIV. The potential breakthrough centers on the experience of a single 51-year-old French man, who has been receiving treatment in Paris for advanced-stage non-small cell lung cancer for the past year. The patient – who is also HIV-positive – had undergone both surgery and chemotherapy for tumors that had initially been diagnosed in 2015, before he experienced a relapse in 2016. So, French clinicians gave him the cancer treatment nivolumab (Opdivo). The drug is commonly used for ... Read more

Related support groups: HIV Infection, Lung Cancer, Non-Small Cell Lung Cancer, Opdivo, Nivolumab

Commitment Is Key for Online Quit-Smoking Groups

Posted 13 Nov 2017 by

MONDAY, Nov. 13, 2017 – An online social network designed to help you quit smoking can do just that, a new study finds. But the odds of quitting rise along with the level of active involvement, the researchers said. They examined the impact of, a social network site created by the nonprofit anti-tobacco group Truth Initiative, in collaboration with the Mayo Clinic. Network users can share information and support through blogs, forums and messages. More than 800,000 people have registered since the network was launched in 2008. The study included more than 2,600 smokers who signed up on After three months, 21 percent of those who actively contributed content on the site had quit smoking, compared with 11 percent who only read others' posts and 8 percent of those who never visited the site. Researchers from the Truth Initiative and the University of Iowa ... Read more

Related support groups: Smoking, Smoking Cessation, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Small Cell Lung Cancer, Nicoderm CQ, Nicotrol Inhaler, Commit, Habitrol, Nicotrol TD, Nicorelief, Nicorette DS, Nicotrol NS, Bronchogenic Carcinoma, ProStep

FDA Approves Alecensa (alectinib) as First-Line Treatment for ALK-Positive Metastatic Non-Small Cell Lung Cancer

Posted 13 Nov 2017 by

South San Francisco, CA – November 6, 2017 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Alecensa (alectinib) for the treatment of people with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. The approval is based on results from the Phase III ALEX study, which showed Alecensa significantly reduced the risk of disease worsening or death (progression-free survival, PFS) by 47 percent (HR=0.53, 95 percent CI: 0.38, 0.73, p Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Alecensa, Alectinib

Patients' Gut Bugs May Play Role in Cancer Care

Posted 3 Nov 2017 by

THURSDAY, Nov. 2, 2017 – The type of bacteria that cancer patients harbor in the gut might affect their odds of responding to certain treatments, two early studies hint. The research, in humans and mice, adds to evidence that gut bacteria play a key role in the immune system. But experts stressed it's too soon to make recommendations to cancer patients – including whether they should take "probiotic" supplements. Both studies looked at whether there's a link between patients' gut bacteria and their responses to newer cancer drugs called PD-1 inhibitors. The drugs, which include Keytruda (pembrolizumab) and Opdivo (nivolumab), work by freeing up the immune system to attack cancer cells. The drugs are approved for several cancers, including advanced cases of melanoma, lung, bladder and stomach cancers. In one study, researchers focused on 112 patients with advanced melanoma, the ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Opdivo, Keytruda, Bladder Cancer, Nivolumab, Pembrolizumab, Gastrinoma

Speed Up the 'Cancer Moonshot,' Doctors Urge

Posted 1 Nov 2017 by

TUESDAY, Oct. 31, 2017 – The Cancer Moonshot Initiative now has a detailed road map designed to cram a decade's worth of medical advancement into half that time. A new report, authored by more than 50 leading U.S. cancer doctors, highlights 13 priority areas for improving the medical response to cancer, along with measurable goals and a specific timeline for meeting each of those objectives. The plan is intended to help "accelerate existing progress so that we deliver in five years what would have historically taken 10," said Dr. Cliff Hudis, chief executive officer of the American Society of Clinical Oncology and co-author of the report. It was created by The Lancet Oncology Commission on Future Research Priorities in the USA. In late 2016, Congress appropriated $1.8 billion for cancer research funding over the next seven years for the so-called Cancer Moonshot, said commission ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Prostate Cancer, Fluorouracil, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Tasigna, Xeloda, Sprycel, Herceptin, Hydroxyurea, Mercaptopurine, Cervical Cancer, Hydrea, Cisplatin, Carboplatin

Survival Odds Improving for Lung Cancer Patients

Posted 26 Oct 2017 by

THURSDAY, Oct. 26, 2017 – In a finding that offers some hope to those fighting lung cancer, researchers report that survival rates have improved among those with early stage disease. "More and more patients are being cured of lung cancer, with both surgery and radiation as good treatment options," said study author Dr. Nirav Kapadia, from the Dartmouth-Hitchcock Medical Center in New Hampshire. "Our study optimistically suggests that if current trends persist, survival for [non-small-cell lung cancer] will continue to improve over time," he said. The study included more than 65,000 people diagnosed with stage 1 non-small-cell lung cancer between 2000 and 2010. Of that group, 62 percent had surgery, 15 percent received radiation therapy, 3 percent had both surgery and radiation and 18 percent received neither treatment. The two-year survival rate for people treated with either surgery ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Bronchogenic Carcinoma

Many Cancer Patients Skimp on Treatment Due to Cost

Posted 24 Oct 2017 by

TUESDAY, Oct. 24, 2017 – The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals. Commissioned by the American Society of Clinical Oncology (ASCO), the report found that 27 percent of cancer survivors or close relatives of a cancer patient said they'd skipped doctor visits or taken other steps to reduce health costs. To save money, nearly one in 10 said they had avoided doctor appointments. Eight percent had refused treatment; postponed filling or not filled prescriptions; or skipped doses of prescribed medications. And 7 percent said they had cut pills in half, according to the survey of more than 4,000 adults. Such measures can jeopardize treatment success, ASCO says. "We should all be alarmed that Americans are potentially risking not only their health, but also their lives, due to ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Methotrexate, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Zoladex, Votrient, Letrozole

Tighter Rules on Arsenic in Water Saved Lives: Study

Posted 23 Oct 2017 by

MONDAY, Oct. 23, 2017 – U.S. government limits on arsenic in drinking water has likely averted hundreds of cases of lung and bladder cancer annually, a new study suggests. After the Environmental Protection Agency introduced tighter limits on arsenic in public drinking water in 2006, there was a 17 percent decrease in levels of arsenic in the urine of people served by public water systems that complied with the rule, the researchers found. Not only that, but there were an estimated 200 fewer cases of lung and bladder cancer a year after the tougher rules were put in place. Levels of arsenic in the urine of people who used private wells did not change, according to the study published Oct. 23 in The Lancet Public Health journal. Arsenic is a carcinogen that naturally occurs in drinking water across the United States. The study findings highlight the important role that government ... Read more

Related support groups: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Skin Cancer, Bladder Cancer, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Trisenox, Bronchogenic Carcinoma, Arsenic Trioxide

Pollution Tied to 9 Million Deaths Worldwide in 2015

Posted 20 Oct 2017 by

FRIDAY, Oct. 20, 2017 – Pollution led to more than 9 million deaths worldwide in 2015, or 1 in 6 deaths that year, a new report reveals. Air pollution, the worst culprit, was linked to 6.5 million heart- and lung-related deaths, The Lancet Commission on Pollution and Health said. Water pollution was tied to 1.8 million deaths, mostly from gastrointestinal and parasitic infections. And workplace-related pollution and lead pollution also played a role, contributing to 800,000 deaths and 500,000 deaths, respectively. "Pollution is much more than an environmental challenge – it is a profound and pervasive threat that affects many aspects of human health and well-being," said Dr. Philip Landrigan, co-lead of the commission. "It deserves the full attention of international leaders, civil society, health professionals, and people around the world," added Landrigan, a professor at the Icahn ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Heart Disease, Ischemic Stroke, Bronchitis, Lung Cancer, Fluticasone, Non-Small Cell Lung Cancer, Qvar, Ribavirin, Budesonide, Flovent, Entocort, Tobramycin, Entocort EC, Mometasone, Prevention of Cardiovascular Disease, Ischemic Stroke - Prophylaxis, Cardiovascular Risk Reduction, Bronchiectasis, Beclomethasone

More Hardcore Smokers Trying to Kick the Habit

Posted 11 Oct 2017 by

WEDNESDAY, Oct. 11, 2017 – More "hardcore" smokers than ever are trying to extinguish their bad habit, new research suggests. "Even though they smoke more than the general population, smokers with high psychological distress have been smoking less and trying to quit more, as the overall level of smoking has decreased," said study author Margarete Kulik. She's a postdoctoral fellow at the University of California, San Francisco's Center for Tobacco Control Research and Education. "This shows that with effective tobacco control policies, even hardcore smokers will soften over time," Kulik said in a UCSF news release. For the study, researchers analyzed health data from the U.S. Census Bureau. Almost 120,000 smokers were asked about their daily cigarette habit and any attempts to quit smoking for at least one day over the past 12 months. The survey also included information collected on ... Read more

Related support groups: Smoking, Smoking Cessation, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Nicoderm CQ, Prevention of Cardiovascular Disease, Nicotrol Inhaler, Commit, Cardiovascular Risk Reduction, Habitrol, Nicotrol TD, Nicorelief, Nicorette DS, Nicotrol NS, ProStep

Health Tip: Screening for Lung Cancer

Posted 4 Oct 2017 by

-- Lung cancer is one of the deadliest forms of cancer, and often lacks symptoms in its earliest stages. That's what makes lung cancer screening so important, the American Lung Association says. The organization provides this additional information: Screening can help find lung cancer at an early stage when it is easier to treat. A low (radiation) dose CT scan may reduce your chances of dying from lung cancer. This imaging process takes a series of pictures as you lie on a table that slides in and out of a scanning machine. Lung cancer screening is not suitable for everyone, but may be recommended for those at high risk for developing the disease. Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Diagnosis and Investigation, Bronchogenic Carcinoma

Switch From Smoking to Vaping Could Save Over 6 Million U.S. Lives

Posted 3 Oct 2017 by

MONDAY, Oct. 2, 2017 – Millions of cigarette smokers could live substantially longer if electronic cigarettes are embraced as a replacement for tobacco during the next decade, a new study contends. As many as 6.6 million cigarette smokers could live a combined 86.7 million more years under policies that encourage them to swap their smokes for e-cigarettes, according to "optimistic" projections from cancer researchers at Georgetown University in Washington, D.C. Even a worst-case scenario involving e-cigarettes would still save lives, the researchers said. Under a "pessimistic" projection, 1.6 million former cigarette smokers would have a combined 20.8 million more years of additional life, the research team found. These numbers show that adopting e-cigarettes as an alternative to smoking could prove the easiest way to cause tobacco use to dwindle in the United States, said lead ... Read more

Related support groups: Cough, Smoking, Chronic Obstructive Pulmonary Disease, Smoking Cessation, Chronic Obstructive Pulmonary Disease, Maintenance, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Small Cell Lung Cancer, Nicoderm CQ, Chronic Obstructive Pulmonary Disease, Acute, Nicotrol Inhaler, Commit, Respiratory Tract Disease, Habitrol, Bronchogenic Carcinoma, Nicotrol TD, Nicorelief, Nicorette DS

Fewer Uninsured Cancer Patients After Medicaid Expansion

Posted 27 Sep 2017 by

WEDNESDAY, Sept. 27, 2017 – States that expanded Medicaid under the Affordable Care Act halved the number of uninsured cancer patients, a new U.S. study finds. This matters because "uninsured cancer patients are more likely to go without needed care and treatment, such as radiation therapy or surgery to remove tumors," said study lead author Dr. Fumiko Chino. She is a radiation oncology resident at the Duke University School of Medicine. Chino and her colleagues analyzed the records of more than 197,000 cancer patients ages 18 to 64. All were newly diagnosed with cancer between 2011 and 2014 and received radiation as part of their treatment. The percentage of uninsured patients fell 52 percent on average in states that expanded Medicaid, while Medicaid enrollment rose from 15 to 18 percent. Medicaid is the publicly funded insurance program for the poor. In states that did not expand ... Read more

Related support groups: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Skin Cancer, Cervical Cancer, Testicular Cancer, Solid Tumors

Radiation and Chemotherapy Together Boost Lung Cancer Survival

Posted 27 Sep 2017 by

TUESDAY, Sept. 26, 2017 – Combining radiation therapy with chemotherapy has substantially extended survival for many people with lung cancer, two new studies report. About 32 percent of non-small cell lung cancer patients who received chemoradiation therapy were still alive five years following treatment, a survival rate double that of previous estimates, according to results from a long-term clinical trial. Further, a small second clinical trial of people with lung cancer that had already spread to other parts of the body showed that radiation therapy added to chemo dramatically slowed the time until these cancers progressed further. The two studies show that radiation therapy and chemotherapy work well together, and that radiation also might help patients who are undergoing newer forms of cancer treatment like targeted therapy and immunotherapy, said Dr. Benjamin Movsas, a radiation ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Bronchogenic Carcinoma, History - Radiation Therapy

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Lung Cancer

Related Drug Support Groups

methotrexate, Tarceva, Avastin, Opdivo, Taxol, Keytruda, Taxotere, Xalkori, cisplatin, view more... capecitabine, cyclophosphamide, Gemzar, nivolumab, gemcitabine, paclitaxel, erlotinib, Tecentriq, Iressa, Cyramza, pembrolizumab, crizotinib, Abraxane, docetaxel, ramucirumab, Alimta, Gilotrif, Platinol, bevacizumab, vinorelbine, cetuximab, gefitinib, Navelbine, afatinib, Methotrexate LPF Sodium, Tagrisso, Mvasi, pemetrexed, osimertinib, Photofrin, Alunbrig, paclitaxel protein-bound, Alecensa, Portrazza, porfimer, ceritinib, Zykadia, necitumumab, Onxol, alectinib, Docefrez, atezolizumab, brigatinib, Ethyol, Platinol-AQ, Folex PFS, Trexall, amifostine